Skip to main content
. 2019 Jun 26;134(8):678–687. doi: 10.1182/blood.2019001144

Figure 3.

Figure 3.

Survival outcomes according to treatment type and intensity. (A) PFS according to type of first-line therapy (lymphoid vs myeloid) (n = 44). (B) PFS according to intensity of first-line treatment (n = 44). PFS was compared between groups by using a log-rank test. All P values reported are 2-sided and considered significant if <.05.